ArticleCell death discovery2022

ECM1 modified HF-MSCs targeting HSC attenuate liver cirrhosis by inhibiting the TGF-β/Smad signaling pathway.

Qi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.